DaVita Inc.

217 articles with DaVita Inc.

• DaVita Inc. 4th Quarter 2019 Results

  2/10/2020

  DaVita Inc. announced results for the quarter and year ended December 31, 2019..

• DaVita Inc. Schedules 4th Quarter 2019 Investor Conference Call

  1/29/2020

  DaVita Inc., announced that it will hold its quarterly conference call to discuss fourth quarter results on Monday, February 10, 2020, at 5:00 p.m. Eastern Time.

• DaVita Inc. 3rd Quarter 2019 Results

  11/5/2019

  DaVita Inc. announced results for the quarter ended September 30, 2019..

• DaVita Selects its Next Chief Accounting Officer

  10/29/2019

  DaVita Inc. announced the selection of its next Chief Accounting Officer, John Winstel.

• DaVita Health Solutions Becomes Vively Health™

  10/28/2019

  Vively embodies company's mission to deliver innovative, comprehensive care to the highest risk patients managing multiple chronic conditions

• DaVita Inc. Schedules 3rd Quarter 2019 Investor Conference Call

  10/24/2019

  DaVita Inc., announced that it will hold its quarterly conference call to discuss third quarter results on Tuesday, November 5, 2019, at 5:00 p.m. Eastern Time.

• Elite Dental Partners Announces New CEO

  10/17/2019

  Elite Dental Partners has named Gaurav Bhattacharyya as CEO. Bhattacharyya has been President of EDP since July.

• DaVita's Corporate Responsibility Efforts Earn Accolades from Dow Jones

  10/16/2019

  Company makes Dow Jones Sustainability Indices for the third time

• 13th Annual Tour DaVita Cycling Event Raises $1.2M for Bridge of Life

  10/10/2019

  Cyclists collectively rode more than 90,000 miles through Pennsylvania to raise awareness about kidney disease

• DaVita Inc. Schedules Capital Markets Day for September 10, 2019

  8/27/2019

  DaVita Inc. announced that it will hold its Capital Markets Day in New York City on Tuesday, September 10, 2019, from 8:30 a.m. to 11:30 a.m. Eastern Time.

• Davita Announces Final Results Of Self-Tender Offer

  8/22/2019

  DAVITA INC. announced the final results of its modified "Dutch auction" tender offer for up to $1.2 billion of its common stock at a price per share not less than $53.50 and not more than $61.50, which expired at 12:00 midnight, New York City time, at the end of the day on August 16, 2019.

• A Force for Change: DaVita Continues to Prioritize Environmental Sustainability

  8/21/2019

  DaVita Kidney Care, celebrated its 2019 sustainability milestones

• DaVita Announces Preliminary Results Of Self-Tender Offer

  8/19/2019

  The total of 21,969,132 shares that the Company expects to accept for repurchase represents approximately 13.7% of the Company's total outstanding shares of common stock as of August 16, 2019. 

• DaVita Announces New Senior Secured Credit Agreement

  8/12/2019

  DAVITA INC. (NYSE: DVA) ( "DaVita" or the "Company"), a Fortune 500® health care provider focused on transforming care delivery to improve quality of life for patients around the globe and the largest provider of kidney care services in the U.S., announced today that it has entered into a new $5.5 billion senior secured credit agreement, dated as of August 12, 2019

• DaVita Inc. 2nd Quarter 2019 Results

  8/1/2019

  DaVita Inc. (NYSE: DVA) today announced results for the quarter ended June 30, 2019.

• DaVita Health Solutions Grows Leadership Team

  7/31/2019

  Dr. Dorothy Fisher and Ian Laird help lead team in providing home-based primary care to the nation's Most Vulnerable Patients (MVPs)   [31-July-2019]   DENVER , July 31, 2019 /PRNewswire/ --  DaVita Health Solutions  today announced two additions to its leadership team: Dr. Dorothy "Dody" Fisher, national medical director, and Ian Laird , national vice president of growt

• DaVita Commences Self-Tender Offer To Purchase For Cash Shares Of Its Common Stock For An Aggregate Purchase Price Of No More Than $1.2 Billion At A Purchase Price Of Not Less Than $53.50 Per Share And Not More Than $61.50 Per Share

  7/22/2019

  DAVITA INC. announced that it has commenced a modified "Dutch auction" tender offer for up to $1.2 billion of its common stock at a price per share not less than $53.50 and not greater than $61.50.

• DaVita Inc. Schedules 2nd Quarter 2019 Investor Conference Call

  7/22/2019

  DaVita Inc., a leading provider of kidney care services in the United States and in 9 countries around the world, announced that it will hold its quarterly conference call to discuss second quarter results on Thursday, August 1, 2019, at 5:00 p.m. Eastern Time.

• DaVita Inc. Announces Preliminary Second Quarter 2019 Results and Updated Guidance for Fiscal Year 2019

  7/22/2019

  DaVita Inc., announced preliminary second quarter 2019 financial and operating results and updated guidance for fiscal year 2019.

• DaVita Statement on Advancing American Kidney Health

  7/10/2019

  DaVita Kidney Care appreciates President Trump, the Administration and Secretary Azar for taking steps to improve the lives of kidney patients.